The MeAgain Index is a quarterly ranking of the Top GLP-1 Brands, Trending GLP-1 Products and Leading GLP-1 Meds. Our proprietary methodology combines real-world data from hundreds of thousands of members on the MeAgain platform with select signals from across the GLP-1 ecosystem.

Learn more about the MeAgain Index

Editions

Coming January 2027

Alani Nu Witch's Brew, Premier Protein Pumpkin Spice shake, Fairlife Nutrition Plan Vanilla, Chobani Pumpkin Spice creamer and Smartfood Fiber Pop Sweet & Salty.Q3 2026

Functional or Trendy? Yes Please

Kraft PowerMac Mac & Cheese, Starbucks Coffee & Protein Caffè Mocha, Javvy Clear Protein Refreshers Strawberry Acai and Doritos Protein Nacho Cheese.Q2 2026

Protein Is Everywhere All at Once

Premier Protein Coffeehouse Caramel Macchiato, Fairlife Nutrition Plan Vanilla, Chobani 20G Protein Vanilla, Oikos Pro Vanilla and Quest Chocolate Chip Cookie Dough protein bar.Q1 2026

Legacy Protein is Still Winning. For Now.

MeAgain Index and data featured in

  • Yahoo
  • The Washington Times
  • MarketWatch
  • Inc.

Methodology

What is the MeAgain Index?

The MeAgain Index is a quarterly ranking of the Top GLP-1 Brands, Trending GLP-1 Products and Leading GLP-1 Meds. Our proprietary methodology combines real-world data from hundreds of thousands of members on the MeAgain platform with select signals from across the GLP-1 ecosystem.

How the MeAgain Index is calculated

MeAgain's real-world behavior data from hundreds of thousands of users and millions of consumer products is the foundation of the index methodology. We combine this internal data with signals across the wider GLP-1 ecosystem, including product launches, brand and retailer partnerships, clinical trial data, new research, social media trends, demand & visibility in AI channels and third-party reported data. Figures from the MeAgain platform are always adjusted for the growth of our member base. The MeAgain Index methodology is built on three dimensions: Access, Use and Impact as described in depth below.

Access

  1. Easy to find

    Visibility in web search and AI discovery, online access and delivery, and how widely it is stocked at pharmacies and retailers nationwide.

  2. Easy to understand

    Clear and accurate labeling and marketing that show it suits GLP-1 users, with proven claims the everyday consumer can easily understand.

  3. Easy to buy

    Price and affordability (including membership constraints), insurance coverage where it applies, and availability through official channels.

Use

  1. Interest

    In-app, web and AI discovery search volumes, plus conversations on social media and on the MeAgain platform that show initial demand.

  2. Adoption

    How much people consume a product or brand, or how many start a medication, based on real-world observed data.

  3. Adherence and retention

    How consistently people keep consuming a product or brand, or taking a medication, based on real-world observed data.

Impact

  1. Health outcomes

    Functional benefits of products, such as protein or fiber, and weight loss, side effects or other health outcomes driven by medications.

  2. Quality-of-life improvements

    Changes or outcomes that impact daily life, including energy, self-esteem, or relationships.

  3. Consumer sentiment

    Social listening across posts and comments on Reddit, TikTok, Instagram and YouTube, plus ratings, reviews and poll comments on the MeAgain platform.

How often the MeAgain Index is published

The MeAgain Index is published every quarter.

A living methodology

We expect the MeAgain Index to keep evolving as the MeAgain platform grows, consumer trends shift and GLP-1 treatment continues to change. We will add new data sources over time. The exact formula used in the MeAgain Index is not disclosed.

For more information about the MeAgain Index please contact index@meagain.com

Get the next MeAgain Index first

Leave your email and we'll let you know as soon as the next edition is out.

Q4 2026Coming soon

MeAgain Index

Leave your email and we'll let you know as soon as the next edition is out.